share_log

Arrowhead Pharmaceuticals | 10-K: FY2024 Annual Report

SEC ·  Nov 27 11:32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.